Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Learn ways to align every expenditure with your financial goals. Prioritize essential spending, reduce waste, and monitor goal progress.
23,330 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
OpenAI has released GPT-5.6 to a limited group of users, signaling a cautious, policy-conscious rollout. This cautiou...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
Wix has endured a brutal stock down year, dropping roughly 70% as growth worries and macro headwinds hit software nam...
In a $520 billion, fragmented remodeling market, larger players use scale and financing access to win more projects, ...
A notable fund pulled out of a multi-million dollar DNOW position last quarter, triggering questions about strategy a...
As 2026 unfolds, investors are watching novavax (nvax) 2026 earnings for clarity on demand, pipeline milestones, and ...
Markets are weighing policy moves that could lift earnings for select U.S. tech and EV names. Here are the players mo...
Nasdaq’s Bitcoin options approval marks a regulatory milestone, paving the way for QBTC to trade inside the US option...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
While headlines chase the next unicorn, a lesser-known tech stock is quietly gaining traction. Here’s how Wall Street...
VOO crossed the $1 trillion mark, the first ETF ever to do so. Yet nearly 40% of the fund sits in mega-cap tech names...